Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colonic Neoplasms × Celecoxib × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Medulloblastoma 2 Ependymoma 2 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Rectal Neoplasms 1 Pinealoma 1 Pancreatic Cancer Metastatic 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Melanoma 1 Histiocytosis, Langerhans-Cell 1 Colonic Neoplasms 1 Carcinoma 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Cetuximab 13 Oxaliplatin 12 Fluorouracil 10 Leucovorin 9 Bevacizumab 9 pembrolizumab 7 Irinotecan 7 Nivolumab 6 Capecitabine 5 Folfox protocol 4 encorafenib 3 dostarlimab 3 Trastuzumab 3 Specimen Handling 3 Pemetrexed 3 Magnetic Resonance Spectroscopy 3 Immune Checkpoint Inhibitors 3 Gemcitabine 3 Exercise 3 Cisplatin 3 Carboplatin 3 trifluridine tipiracil drug combination 2 regorafenib 2 pertuzumab 2 fludarabine 2 dehydroftorafur 2 adagrasib 2 Watchful Waiting 2 Radiotherapy 2 Paclitaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03026140 2026-03-05

NICHE

The Netherlands Cancer Institute

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡